发明名称 |
N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors |
摘要 |
This invention relates to compounds of formula I;
their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, Ar, R1, R2, R3 have meanings given in the description. |
申请公布号 |
US8822464(B2) |
申请公布日期 |
2014.09.02 |
申请号 |
US201213684606 |
申请日期 |
2012.11.26 |
申请人 |
Boehringer Ingelheim International GmbH |
发明人 |
Grauert Matthias;Bischoff Daniel;Dahmann Georg;Kuelzer Raimund;Rudolf Klaus |
分类号 |
A61K31/5377;A61K31/496;A61K31/497;A61K31/501;A61K31/506;A61K31/52;C07D231/12;C07D473/34;C07D401/12;C07D403/12;C07D401/14;C07D403/14;A61K31/53;C07D409/14;C07D401/06;C07D413/14 |
主分类号 |
A61K31/5377 |
代理机构 |
|
代理人 |
Morris Michael P.;Bottino Anthony P. |
主权项 |
1. A compound selected from the group consisting ofor a physiologically acceptable salt thereof. |
地址 |
Ingelheim am Rhein DE |